Immupharma PLC Directorate Change (1938D)
October 23 2015 - 1:00AM
UK Regulatory
TIDMIMM
RNS Number : 1938D
Immupharma PLC
23 October 2015
FOR IMMEDIATE RELEASE 23 OCTOBER 2015
BOARD CHANGE
ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the
specialist drug discovery and development company, announces that
Ajay Agrawal has stepped down as Non-Executive Director with
immediate effect.
Tim McCarthy, Non-Executive Chairman said: "We would like to
thank Ajay for his contribution whilst at ImmuPharma.
"In the short period of time as Chairman, I have become more
convinced of our lead programme Lupuzor. This has the potential to
bring success for ImmuPharma, reward our long standing shareholders
and ultimately to provide a significant treatment for lupus
sufferers, globally. I am delighted to be part of the team driving
this strategy forward."
-Ends-
For further information please contact:
+ 44 (0) 20
ImmuPharma plc 7152 4080
Tim McCarthy, Chairman
Lisa Baderoon, Head of Investor + 44 (0) 7721
Relations 413496
Panmure, Gordon & Co., NOMAD & +44 (0) 20 7886
Broker 2500
Fred Walsh, Duncan Monteith, Corporate
Finance
Charles Leigh-Pemberton, Corporate
Broking
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAPKBDQNBDBAKB
(END) Dow Jones Newswires
October 23, 2015 02:00 ET (06:00 GMT)
Immupharma (LSE:IMM)
Historical Stock Chart
From Apr 2024 to May 2024
Immupharma (LSE:IMM)
Historical Stock Chart
From May 2023 to May 2024